Back to RYTM
JPMORGAN CHASE & CO RYTM Position History
Rhythm Pharmaceuticals, Inc. • Healthcare
Quarters held
25
Latest value
$18.2M
Q2 2026
Peak value
$259.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $370K |
| Q3 2025 | $15.2M |
| Q3 2025 | $3.6M |
| Q3 2025 | $93.1M |
| Q3 2025 | $7.7M |
| Q4 2025 | $8.2M |
| Q4 2025 | $4.9M |
| Q4 2025 | $336K |
| Q4 2025 | $138.9M |
| Q4 2025 | $1K |
| Q1 2026 | $77 |
| Q1 2026 | $110.1M |
| Q1 2026 | $33K |
| Q1 2026 | $850 |
| Q1 2026 | $3.6M |
| Q1 2026 | $6.2M |
| Q2 2026 | $440 |
| Q2 2026 | $8K |
| Q2 2026 | $3.9M |
| Q2 2026 | $451K |
| Q2 2026 | $10M |
| Q2 2026 | $259.7M |
| Q2 2026 | $12K |
| Q2 2026 | $1K |
| Q2 2026 | $18.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $18.2M | 165.2K | — | — |
| Q2 2026 | $1K | 12 | — | — |
| Q2 2026 | $12K | 105 | — | — |
| Q2 2026 | $259.7M | 2.36M | — | — |
| Q2 2026 | $10M | 91.0K | — | — |
| Q2 2026 | $451K | 4.1K | — | — |
| Q2 2026 | $3.9M | 35.2K | — | — |
| Q2 2026 | $8K | 71 | — | — |
| Q2 2026 | $440 | 4 | — | — |
| Q1 2026 | $6.2M | 80.3K | — | — |
| Q1 2026 | $3.6M | 47.0K | — | — |
| Q1 2026 | $850 | 11 | — | — |
| Q1 2026 | $33K | 426 | — | — |
| Q1 2026 | $110.1M | 1.43M | — | — |
| Q1 2026 | $77 | 1 | — | — |
| Q4 2025 | $1K | 11 | — | — |
| Q4 2025 | $138.9M | 1.30M | — | — |
| Q4 2025 | $336K | 3.1K | — | — |
| Q4 2025 | $4.9M | 46.0K | — | — |
| Q4 2025 | $8.2M | 77.0K | — | — |
| Q3 2025 | $7.7M | 76.3K | — | — |
| Q3 2025 | $93.1M | 921.8K | — | — |
| Q3 2025 | $3.6M | 35.5K | — | — |
| Q3 2025 | $15.2M | 150.8K | — | — |
| Q3 2025 | $370K | 3.7K | — | — |
Other funds holding RYTM
$285.7M
$285.7M
$197.6M
$181.7M
$174.4M
$174.4M
$168.4M
$149.9M